Difference between revisions of "Normative:Severe course of COVID-19"

From TermiKnowledge
Jump to navigation Jump to search
(Created page with "==Normative== === Variants and synonyms === * * ===Definition=== <small>Source:</small> === Encyclopaedic information === <small>Source:</small> ===Examples=== <bloc...")
 
(formatting)
 
(One intermediate revision by one other user not shown)
Line 3: Line 3:
=== Variants and synonyms ===
=== Variants and synonyms ===


*  
* severe acute respiratory syndrome
 
* severe covid-19
*
===Definition===
 
 
<small>Source:</small>
 
=== Encyclopaedic information ===
 
 
<small>Source:</small>


===Examples===
===Examples===
<blockquote></blockquote><small>Source:</small>  
<blockquote>It has been theorized that NSAIDs, due to upregulation in ACE2 in human target cells, may lead to an increased risk of infection or a more '''severe course of COVID-19''' in those taking NSAIDs. </blockquote><small>Source: https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-covid-19-gl-tx-and-mgmt-v4.4.1.pdf</small>
 
===Collocations===
 
*  
*  


*
*
===Keyness===
===Keyness===
* Severe course of COVID-19: >1000
* severe acute respiratory syndrome: 39
* severe covid-19: 127


*  
*  


===Note===
===Note===
Only two occurrences of the lemma were found in the corpus.

Latest revision as of 20:19, 7 March 2022

Normative

Variants and synonyms

  • severe acute respiratory syndrome
  • severe covid-19

Examples

It has been theorized that NSAIDs, due to upregulation in ACE2 in human target cells, may lead to an increased risk of infection or a more severe course of COVID-19 in those taking NSAIDs.

Source: https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-covid-19-gl-tx-and-mgmt-v4.4.1.pdf

Keyness

  • Severe course of COVID-19: >1000
  • severe acute respiratory syndrome: 39
  • severe covid-19: 127

Note

Only two occurrences of the lemma were found in the corpus.